Healthpeak Properties raises Q3 2026 guidance, signaling strong Life Science segment recovery and growth.

Healthpeak Properties, a significant portfolio holding, has revised its Q3 2026 guidance upward with a funds from operations (FFO) midpoint of $1.77 and an improved payout ratio of 69%, indicating operational strength. The Life Science segment showed a 130 basis point increase in occupancy and positive trends in same-store net operating income, supporting future growth in adjusted funds from operations (AFFO). Management expects recent lease deals to impact earnings within 12–15 months, positioning the company for accelerated AFFO growth as the Life Science market recovers. This outlook underpins a bullish multi-year turnaround thesis for the company.

Healthpeak Properties trades at USD 19.99 on Pluang as of Nov 05, 2026 01:11 WIB, up 2.20% in one day. The stock's dividend yield stands at 6.24%, attracting full buy interest from Pluang users. Its market cap is $13.49 billion, reflecting strong investor confidence amid the company's positive outlook.